Manufacturing

Specialized in liquid pharmaceuticals: Blow-Fill-Seal (BFS) technology and Nasal Spray.

Read More

Development

Your partner in bringing medical innovation to the market.

Read More

About Curida

Highly skilled Development and Manufacturing Organization with ambitions.

Read More

Contact Curida

Pharmaceutical Development or Manufacturing needs?

Contact Us

Operational Excellence in Pharmaceuticals since 1974

Curida is a Contract Development and Manufacturing Organization (CDMO) within the Pharmaceutical industry, based in Norway.

Curida has core competency in state-of-the-art manufacturing of Liquid Pharmaceuticals based on sterile unit-dose Blow-Fill-Seal (BFS) technology and Nasal Spray. The development expertise covers the full service for the development of nasal drug products, and experience on operational excellence is spanning more than 40 years. Curida has produced BFS products since 1989 and offers over three decades of know-how in this technology. Customers range from small start-ups and early stage Biotech companies to Big Pharma.

Curida is a part of an exciting and growing life science sector in Norway, and our vision is to be the National Centre for Industrialization of Medical Innovation. Curida is an active partner and member of Oslo Cancer Cluster.

Latest News

Curida enters long-term agreement with Trimb Healthcare AB

Published: 07 Apr 2017

Press release: Norwegian Contract Development and Manufacturing Organization (CDMO) Curida has entered a long-term agreement with the Swedish pharma company Trimb Healthcare AB. Curida will manufacture a series of liquid products for Trimb Healthcare, using blow-fill-seal (BFS) technology. Curida offers […]

Read More
 

BFS IOA European meeting in Elverum, Norway

Published: 07 Apr 2017

Curida are proud to welcome the BFS International Operators Association to Elverum, Norway in June 2017. Curida builds on more than 30 years of experience in Blow-Fill-Seal manufacturing, and offer a broad range of products through our expertise in this […]

Read More